198 related articles for article (PubMed ID: 26492414)
1. Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.
Brooks SE; Bonney SA; Lee C; Publicover A; Khan G; Smits EL; Sigurdardottir D; Arno M; Li D; Mills KI; Pulford K; Banham AH; van Tendeloo V; Mufti GJ; Rammensee HG; Elliott TJ; Orchard KH; Guinn BA
PLoS One; 2015; 10(10):e0140483. PubMed ID: 26492414
[TBL] [Abstract][Full Text] [Related]
2. An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.
Hardwick N; Buchan S; Ingram W; Khan G; Vittes G; Rice J; Pulford K; Mufti G; Stevenson F; Guinn BA
Cancer Immun; 2013; 13():16. PubMed ID: 23882161
[TBL] [Abstract][Full Text] [Related]
3. T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization.
Rezvani K; Brenchley JM; Price DA; Kilical Y; Gostick E; Sewell AK; Li J; Mielke S; Douek DC; Barrett AJ
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8799-807. PubMed ID: 16361568
[TBL] [Abstract][Full Text] [Related]
4. Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.
Uttenthal B; Martinez-Davila I; Ivey A; Craddock C; Chen F; Virchis A; Kottaridis P; Grimwade D; Khwaja A; Stauss H; Morris EC
Br J Haematol; 2014 Feb; 164(3):366-75. PubMed ID: 24422723
[TBL] [Abstract][Full Text] [Related]
5. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
6. Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.
Dolton G; Lissina A; Skowera A; Ladell K; Tungatt K; Jones E; Kronenberg-Versteeg D; Akpovwa H; Pentier JM; Holland CJ; Godkin AJ; Cole DK; Neller MA; Miles JJ; Price DA; Peakman M; Sewell AK
Clin Exp Immunol; 2014 Jul; 177(1):47-63. PubMed ID: 24673376
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy.
Gannagé M; Abel M; Michallet AS; Delluc S; Lambert M; Giraudier S; Kratzer R; Niedermann G; Saveanu L; Guilhot F; Camoin L; Varet B; Buzyn A; Caillat-Zucman S
J Immunol; 2005 Jun; 174(12):8210-8. PubMed ID: 15944330
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemia.
Westermann J; Lessen A; Schlimper C; Baskaynak G; le Coutre P; Dörken B; Pezzutto A
Br J Haematol; 2006 Jan; 132(1):32-5. PubMed ID: 16371017
[TBL] [Abstract][Full Text] [Related]
9. A novel MHC-associated proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias.
Knights AJ; Weinzierl AO; Flad T; Guinn BA; Mueller L; Mufti GJ; Stevanovic S; Pawelec G
Leukemia; 2006 Jun; 20(6):1067-72. PubMed ID: 16628186
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analyses of leukemia-associated antigen-specific CD8
Rücker-Braun E; Link CS; Schmiedgen M; Tunger A; Vizjak P; Teipel R; Wehner R; Kühn D; Fuchs YF; Oelschlägel U; Germeroth L; Schmitz M; Bornhäuser M; Schetelig J; Heidenreich F
Exp Hematol; 2016 Nov; 44(11):1024-1033.e1. PubMed ID: 27473564
[TBL] [Abstract][Full Text] [Related]
11. CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia.
Xie G; Ivica NA; Jia B; Li Y; Dong H; Liang Y; Brown D; Romee R; Chen J
Nat Biomed Eng; 2021 May; 5(5):399-413. PubMed ID: 33046866
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.
Rezvani K; Yong AS; Tawab A; Jafarpour B; Eniafe R; Mielke S; Savani BN; Keyvanfar K; Li Y; Kurlander R; Barrett AJ
Blood; 2009 Mar; 113(10):2245-55. PubMed ID: 18988867
[TBL] [Abstract][Full Text] [Related]
13. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection.
Wynn KK; Fulton Z; Cooper L; Silins SL; Gras S; Archbold JK; Tynan FE; Miles JJ; McCluskey J; Burrows SR; Rossjohn J; Khanna R
Blood; 2008 Apr; 111(8):4283-92. PubMed ID: 18270323
[TBL] [Abstract][Full Text] [Related]
14. Autologous MHC-dependent leukaemia-reactive T lymphocytes in a patient with chronic myeloid leukaemia.
Coleman S; Fisher J; Hoy T; Burnett AK; Lim SH
Leukemia; 1996 Mar; 10(3):483-7. PubMed ID: 8642866
[TBL] [Abstract][Full Text] [Related]
15. More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers.
Dolton G; Tungatt K; Lloyd A; Bianchi V; Theaker SM; Trimby A; Holland CJ; Donia M; Godkin AJ; Cole DK; Straten PT; Peakman M; Svane IM; Sewell AK
Immunology; 2015 Sep; 146(1):11-22. PubMed ID: 26076649
[TBL] [Abstract][Full Text] [Related]
16. Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.
Kuball J; de Boer K; Wagner E; Wattad M; Antunes E; Weeratna RD; Vicari AP; Lotz C; van Dorp S; Hol S; Greenberg PD; Heit W; Davis HL; Theobald M
Cancer Immunol Immunother; 2011 Feb; 60(2):161-71. PubMed ID: 20963411
[TBL] [Abstract][Full Text] [Related]
17. Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
Guinn BA; Bland EA; Lodi U; Liggins AP; Tobal K; Petters S; Wells JW; Banham AH; Mufti GJ
Biochem Biophys Res Commun; 2005 Oct; 335(4):1293-304. PubMed ID: 16112646
[TBL] [Abstract][Full Text] [Related]
18. Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.
Rezvani K; Grube M; Brenchley JM; Sconocchia G; Fujiwara H; Price DA; Gostick E; Yamada K; Melenhorst J; Childs R; Hensel N; Douek DC; Barrett AJ
Blood; 2003 Oct; 102(8):2892-900. PubMed ID: 12829610
[TBL] [Abstract][Full Text] [Related]
19. Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.
Gannon PO; Wieckowski S; Baumgaertner P; Hebeisen M; Allard M; Speiser DE; Rufer N
J Immunol; 2015 Jul; 195(1):356-66. PubMed ID: 26002978
[TBL] [Abstract][Full Text] [Related]
20. Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?
Riley CL; Mathieu MG; Clark RE; McArdle SE; Rees RC
Cancer Immunol Immunother; 2009 Sep; 58(9):1489-99. PubMed ID: 19259670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
